logo

For the Inventor, By the Inventor

Stanford, CA, United States of America

Leonard A Herzenberg

USPTO Granted Patents = 15

 


Average Co-Inventor Count = 3.4

ph-index = 9

Forward Citations = 983(Granted Patents)


Location History:

  • Stanford, CA (US) (1985 - 2010)
  • Palo Alto, CA (US) (2011)

Company Filing History:

goldMedal13 out of 5,307 
 
Leland Stanford Junior University
 patents
silverMedal1 out of 155 
 
Deutsches Krebsforschungszentrum
 patents
bronzeMedal2 out of 832,812 
Other
 patents
where one patent can have more than one assignee

Years Active: 1985-2011

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 7981625 - Prostate cancer glycan markers and autoantibody signatures (2011-07-19),
2. 7723389 - N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity (2010-05-25),
3. 7650351 - Internet-linked system for directory protocol based data storage, retrieval and analysis (2010-01-19),
4. 6947953 - Internet-linked system for directory protocol based data storage, retrieval and analysis (2005-09-20),
5. 6566401 - N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity (2003-05-20),
6. 6077665 - Rapid assay for infection in neonates (2000-06-20),
7. 5968755 - Methods for determining T-cell profiles of immunocompromised subjects (1999-10-19),
8. 5968738 - Two-reporter FACS analysis of mammalian cells using green fluorescent (1999-10-19),
9. 5843785 - Glutathione deficiency as a prognosis for survival in aids (1998-12-01),
10. 5807715 - Methods and transformed mammalian lymphocyte cells for producing (1998-09-15),
11. 5607974 - Treatment of diseases associated with cysteine deficiency (1997-03-04),
12. 5580577 - Method of treating the symptoms of human rhinovirus infection (1996-12-03),
13. 5070012 - Monitoring of cells and trans-activating transcription elements (1991-12-03),
14. 4695459 - Method of treating autoimmune diseases that are mediated by Leu3/CD4 (1987-09-22),
15. 4510244 - Cell labeling with antigen-coupled microspheres (1985-04-09),

Title: Leonard A. Herzenberg: Innovator in Cancer Research and Drug Toxicity Prevention

Introduction

Leonard A. Herzenberg is a prominent inventor based in Stanford, California. He has made significant contributions to the fields of cancer research and drug toxicity prevention. With a total of 15 patents, his work has had a profound impact on medical science.

Latest Patents

Herzenberg's latest patents include groundbreaking methods for probing immunogenic sugar moieties of prostate cancer cells. These methods detect glyco-epitopes that are highly and differentially expressed among prostate cancers of various Gleason grades. The glyco-epitopes exist on the surfaces of prostate cells and are crucial for understanding prostate cancer. Additionally, he has developed pharmaceutical compositions for the treatment and prevention of drug toxicity using N-acetylcysteine. This invention aims to mitigate the toxic effects of therapeutic agents, enhancing patient safety and treatment efficacy.

Career Highlights

Herzenberg has had a distinguished career, working at Leland Stanford Junior University, where he has contributed to various research initiatives. His innovative approaches have led to advancements in understanding cancer biology and improving therapeutic strategies.

Collaborations

Throughout his career, Herzenberg has collaborated with notable individuals such as Leonore A. Herzenberg and Vernon T. Oi. These partnerships have fostered a collaborative environment that has propelled research forward.

Conclusion

Leonard A. Herzenberg's contributions to cancer research and drug toxicity prevention exemplify the spirit of innovation in the medical field. His patents and collaborative efforts continue to influence the landscape of medical science, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…